أعرض في EDS

1028P BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response – results from the NSCLC cohort

التفاصيل البيبلوغرافية
العنوان: 1028P BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response – results from the NSCLC cohort
المؤلفون: R.N. Fischer, J. George, A. Scheel, H. Schloesser, P. Brossart, W. Engel-Riedel, F. Griesinger, C. Grohé, J.K. Kern, J. Panse, M. Sebastian, M. Serke, R. Wiewrodt, S. Michels, L. Nogova, R. Riedel, J-P. Weber, R. Büttner, R. Thomas, J. Wolf
المصدر: Annals of Oncology. 33:S1025
بيانات النشر: Elsevier BV, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Oncology, Hematology
تدمد: 0923-7534
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1f811baf555d37d2ba807b91b94b6121
https://doi.org/10.1016/j.annonc.2022.07.1154
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........1f811baf555d37d2ba807b91b94b6121
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534